GL1X · GenesisL1 explorer

Research workbench

Crystal structure of V30M mutant human transthyretin complexed with ferulic acid phenethyl ester

Analyse Crystal structure of V30M mutant human transthyretin complexed with ferulic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PWF
Type
protein
Length
229 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
PWF
Pockets
3 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1156% helix, 53% strandP02766
BTransthyretinprotein1146% helix, 50% strandP02766

Ligands and binding sites

  • PWF · 2-phenylethyl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1870.360.7617empty
2720.350.7616empty
3610.260.7216empty

Interfaces

1 interface between chains.

  • A–B · 926 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 4PWF · Crystal structure of V30M mutant human transthyretin complexed with ferulic acid… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.